DePuy Entering Spinal Fusion Cage Market With $325 Mil. AcroMed Purchase
This article was originally published in The Gray Sheet
Executive Summary
DePuy is looking to establish itself as a player in the expanding spinal fusion cage market - currently estimated at $120 mil. and growing rapidly - through the acquisition of AcroMed for $325 mil. The Roche subsidiary announced the cash offer on March 20.
You may also be interested in...
J&J/DePuy Projects SB Charite Artificial Lumbar Disc PMA Submission In 2004
J&J/DePuy Acromed will establish itself as a player in the nascent artificial spinal disc market through the purchase of Link Spine Group for $325 mil., plus additional milestone payments
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.